Dr. Naseer Ally

Naseer Ally is an ophthalmic researcher and clinician whose work bridges retinal imaging, vitreoretinal surgery, and advanced ocular biomaterials. Affiliated with institutions in South Africa and collaborating internationally, research integrates clinical ophthalmology with translational science, particularly in the development and evaluation of novel vitreous substitutes and drug delivery systems for posterior segment disease.

Publications highlight a strong focus on optical coherence tomography–based volumetric analysis in lamellar macular holes, introducing validated methods to quantify retinal structures and identify prognostic biomarkers for surgical outcomes. Clinical studies also examine pars plana vitrectomy in uveitis and the impact of systemic disruptions such as COVID-19 on ophthalmic surgical services across sub-Saharan Africa, reflecting commitment to evidence-based service planning.

A parallel research stream advances polymeric and nano-enabled hydrogels engineered for antifouling performance, sustained corticosteroid delivery, and biomechanical compatibility with the native vitreous. Through in vitro and in vivo evaluation, this work contributes to the design of next-generation ocular implants, positioning contributions at the interface of biomaterials science and vitreoretinal therapeutics.